“showed a trend”

While diabetes mellitus showed a trend toward association with HFpEF in univariate analysis (OR 1.33, 95% CI 0.92–1.92, P = 0.13), it did not reach statistical significance for inclusion in our final model. 3.3.

Patients with AF showed a trend of increased wall motion abnormalities compared with those without AF (11.1% vs. 5.9%, p = 0.13, respectively), whereas patients without AF had a trend to more patent foramen ovale than those with AF (6.6% vs. 0%, p = 0.06, respectively).

On the other hand, the T-allele of rs780094 showed a trend of increased FPG in rs1799884 AA carriers (0.14 mmol/l per allele, P = 0.13) but decreased FPG (−0.05 mmol/l per allele) in GG carriers ( P = 0.0045).

Women who underwent early PBO also showed a trend of greater tau deposition compared to the referent women after adjusting for age (PBO p = 0.13), or for age and APOE ε4 status (PBO p = 0.16), but this difference did not reach statistical significance (Table 2 ).

The results also showed a trend that upgraded patients were older (p = 0.130), with more positive cores (p = 0.608), maximum percentage of cancer in a given core (0.071), and smaller prostates (p = 0.806), but none of these variables were statistically significant.

Again, high‐risk cytogenetics and ISS were found to be statistically significant prognostic factors both for PFS and OS, while HLCr normalization showed a trend for better PFS (HR 0.76, 95% CI 0.53–1.09, p = 0.13; Table 4 ) but not for OS (HR 0.90, 95% CI 0.49–1.65, p = 0.73; Table 5 ).

The pooled result showed a trend toward INV angle increase (SMD = 0.86; 95% CI: −0.24 to 1.95; P = 0.13), but without statistical significance.

NADH histological staining on quadriceps muscle ( Figure 4A ) showed a trend towards smaller cross- sectional area (CSA) in light stained fibers in vitamin D insufficient mice (LOW: 3,057.1 ± 708.3 versus STD: 4,046.7 ± 977.1 μm 2 p=0.13, n =4 and 5, respectively , Figure 4B ).

−34.2 ± 8.6 %, p = 0.21) was not significant but showed a trend for improvement (60 ± 11 vs. 64 ± 8 %, p = 0.13).

The quarterly analysis showed a trend for more cases to have onset from July to September and fewer cases from January to March (goodness-of-fit χ 2 = 5.63, p = 0.13).

The pooled results showed a trend favoring the HA group, but did not show any differences (MD 6.01; 95%CI −1.74 to 13.75; P = 0.13).

Additionally, the number of EV particles produced by non-irradiated control SFs and irradiated SF showed a trend (7.7x±3.6 × 10 9 vs. 12.4 ± 6.9 × 10 9 ; p = 0.13) of increased EV particles per cell in irradiated SFs, however this was not statistically significant ( Figure 1G ).

The no-COXi group showed a trend toward longer median progression-free survival (8 months for COXi vs. 13 months for no-COXi groups; p = 0.13).

This cohort showed a trend toward longer median PFS (not reached vs. 15.8 months; both p = 0.13) and a higher 2-year overall survival rate (100% vs. 92.6%; p = 0.46) than those who did not receive surgery (Supplementary Fig.

The effect of sex on stromal thickness in the central 2 mm region was not significant, although it showed a trend towards stromal thinning in females ( P =0.131, Table 2 , t -test).

Moreover, women with EGFR mutant tumor treated with front-line CT and salvage anti-EGFR TKI showed a trend toward a better OS in comparison with those affected by EGFR wild-type tumor undergoing the same sequence (HR 0.560; p = 0.131).

Although non-significant (NS), patients with incongruent results (one low/one high, n = 10) showed a trend of having a favorable prognosis compared to patients with high results from both modalities (log-rank p = 0.131), but inferior compared to patients with low uPAR-estimates on both modalities (p = 0.136).

In terms of medical record access, ROI patients showed a trend towards improved access (37% vs 26%, p=0.131), though the majority of patients in both regions expressed a desire for regular access to their records.

We found that overexpression of WDR66 showed a trend toward an increase of CD10+ cells in RPMI 2650 (p=0.1313), while a decrease in CD10+ (and CD184+) cells was observed in Detroit 562 ( Fig. 3 C ).

Convexity meningiomas showed a trend toward lower odds of preoperative seizures (OR = 0.179; p = 0.132), although this was not statistically significant.

Regarding the influence of DIC, the Firmicutes:Bacteroidetes (F/B) ratio showed a trend of a numerical decrease ( P = 0.132) in the Salmonella trial with DIC (1.14 vs. 1.47 in the CTR group).

Although the 0 and ≥3 positive lesions groups showed a trend toward higher rates of clinical pregnancy ( P =0.132), these differences failed to reach statistical significance.

In a different randomized trial in the adjuvant setting, AE37 and GP2, two other HER2 derived peptide vaccines were investigated in a four-arm, prospective, randomized, single-blinded, multi-center phase II trial; the AE37 arm showed no difference in DFS overall; however, subgroup analyses showed a trend towards benefit in advanced stage ( p = 0.132, HR 0.573 CI 0.275–1.193), HER2 under-expression ( p = 0.181, HR 0.756 CI 0.499–1.145), and triple-negative breast cancer ( p = 0.266, HR 0.443 CI 0.114–1.717).

Although not reaching statistical significance, ID/IN patients showed a trend towards improvements in the sections’ reflexes (change: 0.5 ± 1.1, P = 0.132), lips (change: 1.1 ± 3.9, P = 0.360), and tongue (change: 0.5 ± 1.9, P = 0.389).

The AE37 arm had no difference in DFS as compared to CG, but pre-specified exploratory subgroup analyses showed a trend towards benefit in advanced stage ( p = 0.132, HR 0.573 CI 0.275–1.193), HER2 under-expression ( p = 0.181, HR 0.756 CI 0.499–1.145), and triple-negative breast cancer ( p = 0.266, HR 0.443 CI 0.114–1.717).